The table below summarizes the most recent Bolt Biotherapeutics insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Bolt Biotherapeutics insider buys are important for investors to follow.

Date	Insider	Price	Amount
12-12-2023 Insider Buy	William P. Quinn Chief Financial Officer	$0.95 CAGR »	$11,240.96 11,829 shares
12-8-2021 Insider Buy	William P. Quinn Chief Financial Officer	$7.04 CAGR »	$44,067.05 6,256 shares
2-9-2021 Insider Buy	Holdings A/S Novo >10% Owner	$20.00 CAGR »	$8,000,000.00 400,000 shares
2-9-2021 Insider Buy	Sofinnova Venture Partners X, L.P. >10% Owner	$20.00 CAGR »	$9,000,000.00 450,000 shares
2-9-2021 Insider Buy	Randall C. Schatzman Chief Executive Officer	$20.00 CAGR »	$30,000.00 1,500 shares
2-9-2021 Insider Buy	William P. Quinn Chief Financial Officer	$20.00 CAGR »	$24,000.00 1,200 shares
2-9-2021 Insider Buy	Edgar Engleman Director and >10% Owner	$20.00 CAGR »	$4,000,000.00 200,000 shares
2-9-2021 Insider Buy	Ashish Siri Ram Khanna Director	$20.00 CAGR »	$44,000.00 2,200 shares
2-9-2021 Insider Buy	James Healy Director	$20.00 CAGR »	$9,000,000.00 450,000 shares
2-9-2021 Insider Buy	Kathleen Laporte Director	$20.00 CAGR »	$24,000.00 1,200 shares
2-9-2021 Insider Buy	Vivo Capital VIII, LLC >10% Owner	$20.00 CAGR »	$7,000,000.00 350,000 shares
5-9-2014 Insider Buy	Raymond M. Soto CEO, Chairman	$16.22 CAGR »	$81,100.00 5,000 shares
11-26-2013 Insider Buy	Kevin M. Conlisk Director	$20.00 CAGR »	$100,000.00 5,000 shares
11-21-2012 Insider Buy	Michael C. Hedger COO, PRESIDENT	$14.12 CAGR »	$356,318.20 25,235 shares
12-20-2011 Insider Buy	Joseph Espeso Senior VP Finance	$11.40 CAGR »	$1,048.80 92 shares
11-30-2011 Insider Buy	Michael H. Flynn Director	$11.73 CAGR »	$117,300.00 10,000 shares
11-25-2011 Insider Buy	Peter J. Siciliano Director	$11.25 CAGR »	$11,250.00 1,000 shares

Also See: Institutional Holders of BOLT
Also See: SEC filings

Below we present the annualized performance delivered by Bolt Biotherapeutics stock since 12-12-2023 (the date of the most recent insider purchase). The performance of the investment from the time Bolt Biotherapeutics insider buying occurred is the ultimate test of whether insiders were right about BOLT being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	12/13/2023
End date:	05/02/2024
Start price/share:	$1.01
End price/share:	$1.10
Dividends collected/share:	$0.00
Total return:	8.91%
Annualized Gain:	23.23%
Starting investment:	$10,000.00
Ending investment:	$10,891.00
Years:	0.38

Bolt Biotherapeutics Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Bolt Biotherapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding BOLT

BOLT — Current Quote

Quotes delayed 20 minutes

Free BOLT Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

BOLT — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Bolt Biotherapeutics Insider Buying occurred are:

Brc Insider Buying
Hamilton Insurance Group LTD. Class Bhar Insider Buying
Immix Biopharma Insider Buying
aTyr Pharma Insider Buying
US Energy Insider Buying
RumbleON Insider Buying
NewtekOne Insider Buying
Lesaka Technologies Insider Buying
Sally Beauty Holdings Insider Buying
Aris Water Solutions Insider Buying

Bolt Biotherapeutics Insider Buying

Bolt Biotherapeutics Insider Buying | www.HoldingsChannel.com